Based on 1 analyst offering 12 month price targets for Dr Reddys Laboratories Ltd
Min Forecast
$1,450.00+10,985.63%
Avg Forecast
$1,450.00+10,985.63%
Max Forecast
$1,450.00+10,985.63%
Should I buy or sell RDY stock?
Based on 1 analyst offering ratings for Dr Reddys Laboratories Ltd.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although RDY's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates RDY as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -6.47% per year. Learn More
Be the first to know when Wall Street analysts revise their RDY stock forecasts and price targets.
Is Dr Reddys Laboratories Stock a good buy in 2026, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSE: RDY) stock is to Strong Buy RDY stock.
Out of 1 analyst, 1 (100%) are recommending RDY as a Strong Buy, 0 (0%) are recommending RDY as a Buy, 0 (0%) are recommending RDY as a Hold, 0 (0%) are recommending RDY as a Sell, and 0 (0%) are recommending RDY as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year RDY price target, the average RDY price target is $1,450.00, with the highest RDY stock price forecast at $1,450.00 and the lowest RDY stock price forecast at $1,450.00.
The Wall Street analyst predicted that Dr Reddys Laboratories's share price could reach $1,450.00 by Sep 29, 2027. The average Dr Reddys Laboratories stock price prediction forecasts a potential upside of 10,985.63% from the current RDY share price of $13.08.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.